MilenkoTanasijevicMDMBA

PubMed

• 214 citations
  A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests.
  David W. Bates, Gilad J. Kuperman, Eve Rittenberg, Jonathan M. Teich, Julie M. Fiskio
  The American Journal of Medicine. 1999-02-01
• 14 citations
  How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned.
  Jonathan M. Tsai, Nicole V. Tolan, Athena K. Petrides, Sanjat Kanjilal, Manfred Brigl
  The Journal of Applied Laboratory Medicine. 2021-04-06
• 55 citations
  What Proportion of Vancomycin Trough Levels Are Drawn Too Early? Frequency and Impact on Clinical Actions
  Aileen P. Morrison, Stacy E.F. Melanson, Marcy G. Carty, David W. Bates, Paul M. Szumita
  American Journal of Clinical Pathology. 2012-03-01

Journal Articles

• Use of Potassium Concentrations as a Qualityof-Service Metric for Phlebotomists Detects Systematic Preanalytical Biases and Facilitates Their Correction  
  Greenblatt MB, Torre M, Means J, Tanasijevic M, Pedulla LV, Bunnell CA, Conrad MJ, Jarolim P, Clin Chem, 1/1/2014
• Significant cost savings achieved by in-sourcing urine drug testing for monitoring medical compliance in pain management  
  Melanson S, Jarolim P, Snyder M and Tanasijevic M, Clin Chim Acta, 1/1/2013
• An Intervention to Improve the Timing of Vancomycin Levels  
  Melanson S, Mijailovic AS, Morrison A, Szumita P, Bates DM and Tanasijevic MJ, Am J Clin Path, 1/1/2013
• What proportion of vancomycin trough levels are drawn too early? Frequency and impact on dosing adjustments  
  Morrison A, Melanson SE, Carty MG, Bates DW, Szumita PM, Tanasijevic MJ, Am J Clin Path, 1/1/2012
• Effectiveness of Barcoding for Reducing Patient Specimen and Test Identification Errors: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis  
  Snyder SR, Favoretto A, Derzon J, Shaw C, Baetz RA, Christenson R, Mass D, Fantz C, Raab S, Tanasijevic M, Kahn S and Liebow E, Clinical Biochemistry, 1/1/2012
• Serial serum free light chain measurements do not detect changes in disease status earlier than electrophoretic M-spike measurements in patients with intact immunoglob...  
  Uljon S, Richardson PG, Anderson KC, Tanasijevic, MJ, and Lindeman N, Clin Chim Acta, 1/1/2011
• A Strategy for Optimizing Staffing to Improve the Timeliness of Inpatient Phlebotomy Collections  
  Morrison AP, Tanasijevic MJ, Torrence-Hill J, Goonan E, Gustafson ML, Melanson SEF, Arch Pathol Lab Med, 1/1/2011
• Reduction in specimen labeling errors after implementation of a positive patient identification system in phlebotomy  
  Morrison A, Tanasijevic, MJ, Goonan E, Lobo M, Bates M, Lipsitz S, Bates D, Melanson SEF, Am J Clin Path, 1/1/2010
• Applying Lean/Toyota Production System Principles to Improve Phlebotomy Patient Satisfaction and Workflow  
  Melanson SEF, Goonan EM, Lobo MM, Baum JM, Paredes JD, Santos KS, Gustafson ML, Tanasijevic, MJ, Am J Clin Path, 1/1/2009
• Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsy  
  Vargas SO, Grudzien C, Tanasijevic, MJ, J Thrombo Thromboly, 1/1/2007
• Fetal lung maturity testing in diabetic mothers: Utility of TDx-FLM II surfactant-to-albumin assay, disaturated phosphatidylcholine, and logistic regression models  
  Fetal lung maturity testing in diabetic mothers: Utility of TDx-FLM II surfactant-to-albumin assay, disaturated phosphatidylcholine, and logistic regression models., Lab Med, 1/1/2007
• Validation of a formula that calculates the estimated risk of respiratory distress syndrome  
  Melanson S, Berg A, Jarolim P, Tanasijevic, MJ, McElrath T, Ob Gyn, 1/1/2006
• Return on investment for a computerized physician order entry system  
  Kaushal R, Jha AK, Franz C, Shetty KD, Glaser j, Jaggi T, Middleton B, Kuperman GJ, Khorasani R, Tanasijevic M, Bates DW, BWH CPOE Working Group, Journal of The American Medical Informatics Association (JAMIA), 1/1/2006
• Evaluation of coronary artery patency using cardiac markers  
  Tanasijevic, MJ, Journal of Thrombosis and Thrombolysis, 1/1/2005
• Laboratory diagnosis of acute myocardial injury  
  Melanson S, Tanasijevic, MJ, Cardiovasc Path, 1/1/2005
• Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates  
  Chan RK, Ibrahim SI, Pil P, Tanasijevic M, Moore, Jr FD, Archiv Surgery, 1/1/2005
• Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation  
  Dorfman DM, Goonan EM, Boutlier MK, Jarolim P, Tanasijevic, MJ, Goldhaber SZ, Vasc Med, 1/1/2005
• Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia  
  Sabatine M, Morrow DA, deLemos JA, Omland T, Desani MY, Tanasijevic, MJ, Hall C, McCabe CH, Braunwald E, JACC, 1/1/2004
• Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ration  
  McElrath TF, Colon I, Hecht J, Tanasijevic, MJ, Norwitz ER, Ob Gyn, 1/1/2004
• A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring  
  Chen P, Tanasijevic, MJ, Schoenenberger RA, Fiskio J, Kuperman GJ and Bates DW, AJCP, 1/1/2003
• Process improvements to support earlier discharge times on a cardiology service  
  Goldszer RC, Moore ML, Hird L, Kirshenbaum J, Epstein L, Goonan E, DelVecchio M, Tanasijevic M, JCOM, 1/1/2003
• Ten commandments for effective clinical decision support Making the practice of evidence-based medicine a reality  
  Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, Spurr C, Khorasani R, Tanasijevic M, Middleton B, Journal of The American Medical Informatics Association (JAMIA), 1/1/2003
• Clinical effectiveness of cardiac markers as indicators of coronary artery patency after thrombolysis for acute myocardial infarction  
  Fischer G, Cannon CP, Tanasijevic, MJ, Chest Pain (Online), 3/1/2002
• Noninvasive testing in the clinical laboratory  
  Winkelman JW, Tanasijevic, MJ, Clin Lab Med, 1/1/2002
• Comparison of the tandem-E immuno-enzymetric and immuno-1 PSA assays  
  Delgado JC, Loughlin KR, Bosch RJ, Tanasijevic M, Lab Med, 1/1/2002
• Join now to see all

Abstracts/Posters

• Are specimen collections for Vancomycin trough concentrations appropriately timed?
  Morrison AP, Tanasijevic, MJ, Carty MG, Szumita P, Melanson SE, American Association for Clinical Chemistry, Anaheim, CA, 1/1/2010
• Biomarkers in Myocardial Injury: Past, Present and Future.
  Milenko Jovan Tanasijevic, MD, 17th Meeting of the Balkan Clinical Laboratory Federation, 5th Macedonian National Congress of Medical Biochemists, Ohrid, Macedonia, 1/1/2009
• Cardiac troponin assays: A view from the clinical chemistry laboratory.
  Melanson SEF, Tanasijevic, MJ, Jarolim P, Circulation, American Heart Association, 1/1/2007
• Non-invasive assessment of coronary artery patency after thrombolysis using serum myoglobin measurements.
  Tanasijevic M, Sec Bio Sci, Proceeding of the Macedonian Academy of Arts and Sciences, 1/1/2007
• Development and implementation of an enterprise-scalable, multi-institutional platform supporting the prospective banking of clinical specimens.
  Bry L, Herring N, Tanasijevic MJ, Weinberg D, AJCP, Session for Scientific Papers, Academy of Clinical Physicians and Scientists, Denver, CO, June 3-5, 2004, 9/1/2004
• The role of total and free PSA in diagnosing and treating prostate cancer.
  Milenko Jovan Tanasijevic, MD, 18th Annual Northeast Joint Fall Conference of Medical technologists, Portland, ME, 1/1/2000
• Non-invasive assessment coronary artery patency using cardiac markers.
  Milenko Jovan Tanasijevic, MD, 1st International Congress of the Macedonian Physicians, Ohrid, Macedonia, 1/1/2000
• Cardiac Troponin-I in postmortem serum specimens.
  Vargas SO, Grudzien C, Tanasijevic MJ, Modern Pathol, 1/1/1999
• ST-segment resolution and serum myoglobin ratio predict reperfusion after thrombolytic therapy A TIMI 14 substudy.
  de Lemos JA, Antman EM, Rifai N, Murphy S, Giugliano RP, Tanasijevic M, McCabe CH, Gibson CM, Braunwald E, J Am Coll Cardiol, 1/1/1999
• Biochemical markers for evaluating patients with unstable angina.
  Milenko Jovan Tanasijevic, MD, Specialty Laboratories, Santa Monica, CA, 1/1/1999
• The prognostic value of cardiac myosin light chains in acute ischemic syndromes Results of TIMI 3B.
  Fung AY, Gawad Y, Thompson CR, Jackowski G, Leitmann R, Antman EM, Tanasijevic MJ, Canner J, Thompson E, Braunwald E, JACC, 2/1/1998
• Risk stratification of patients with unstable coronary syndrome using cardiac Troponin-I.
  Milenko Jovan Tanasijevic, MD, Clinical Pathology Presentation Conference, Massachusetts General Hospital, 1/1/1998
• New model for evaluating patients with chest pain using cardiac Troponin-I.
  Milenko Jovan Tanasijevic, MD, Medical Staff Presentation Conference, Taunton Hospital, Taunton, MA, 1/1/1998
• Serum myoglobin, cardiac troponin I and CK-MB, to assess reperfusion after thrombolysis for acute myocardial infarction. Results from TIMI 10 B.
  Milenko Jovan Tanasijevic, MD, American Heart Association, 70th Scientific Sessions, Orlando, FL, 1/1/1997
• The role of cardiac Troponin-I in evaluation of acute coronary syndromes.
  Milenko Jovan Tanasijevic, MD, New England Medical Center Clinical Laboratories, Boston, MA, 1/1/1997
• Evaluating the appropriateness of digoxin level monitoring.
  Canas F, Tanasijevic MJ, Ma'luf N, Bates DW, J Gen Int Med, 1/1/1997
• Serum myoglobin, cardiac troponin I and CK-MB, to assess reperfusion after thrombolysis for acute myocardial infarction. Results from TIMI 10 B.
  Tanasijevic MJ, Cannon CP, Wybenga D, Fischer G, Grudzien C, McCabe CH, Gibson M, Fischer G, Winkelman JW, Antman EM, Braunwald E, Circ, 1/1/1997
• Cardiac Troponin-I, myoglobin and CK-MB for non-invasive assessment of reperfusion after thrombolytic therapy for acute myocardial infarction.
  Milenko Jovan Tanasijevic, MD, American Heart Association, 69th Scientific Sessions, New Orleans, LA, 1/1/1996
• Role of cardiac Troponin-I in patients with unstable angina results from the TIMI 3B trial.
  Milenko Jovan Tanasijevic, MD, Dade Diagnostics, Phoenix, AZ, 1/1/1996
• Cardiac Troponin-I A novel marker for assessing myocardial injury.
  Milenko Jovan Tanasijevic, MD, Yale University Medical Center, Clinical Laboratories Department, New Haven, CT, 1/1/1996
• Cardiac Troponin I, myoglobin and CK-MB for non-invasive assessment of reperfusion after thrombolytic therapy for acute myocardial infarction.
  Tanasijevic MJ, Cannon CP, Wybenga D, Fischer G, Grudzien C, McCabe CH, Gibson M, Fischer G, Wybenga D, Antman EM, Braunwald E, Circ, 1/1/1996
• Fertility hormone testing in a tertiary hospital setting using the Miles Immuno 1 analyzer.
  Tanasijevic M, Fischer G, Wybenga D, Winkelman J, Proceedings from the Miles International Immuno 1 Symposium, 3/1/1995
• Fertility hormone testing in a tertiary hospital setting using the Miles Immuno 1 analyzer.
  Milenko Jovan Tanasijevic, MD, Presentation sponsored by Miles Diagnostics, Boston, MA, 1/1/1995
• Effect of displaying charges for clinical laboratory tests on patient ordering.
  Bates DW, Kuperman GJ, Jha A, Teich JM, Orav JE, Ma'luf N, Onderdonk A, Pugatch R, Wybenga D, Winkelman J, Brennan TA, Komaroff A, Tanasijevic M, J Gen Intern Med, 1/1/1995
• Reminders for redundant tests results of a randomized controlled trial.
  Bates DW, Kuperman GJ, Rittenberg E, Teich JM, Onderdonk A, Winkelman J, Komaroff AL, Tanasijevic M, Sym Comp Appl Med Care, 1/1/1995
• Join now to see all

Lectures

• Grand Rounds: "Advanced Diagnostics as Strategy for Success for Academic Clinical Laboratory Programs" 
  ARUP Laboratories, Salt Lake City UT - 9/18/2014
• "Brigham and Women's Clinical Laboratories' Strategy for Advanced Diagnostics." 
  Washington University, Department of Pathology, St. Louis MO - 1/1/2011
• "Strategies for managing reference laboratories testing" 
  Washington University, Department of Pathology, St. Louis MO - 1/1/2011
• "GE Lean Process Improvement: The BWH Clinical Laboratories Experience." 
  Chicago, IL - 1/1/2009
• "Advances in Laboratory Medicine" 
  Institute of Pharmacy at the University Cyril and Methodius, Macedonia - 6/1/2008
• "Lab Lean Project" 
  1/1/2008
• "Strategy for Success through Advanced Diagnostics." 
  Cedars Sinai Medical Center, Department of Pathology, Los Angeles, CA - 1/1/2007
• "Advanced Diagnostics as the Catalysts to Personalized Medicine." 
  Institute of Pharmacy at the University Cyril and Methodius, Macedonia - 1/1/2006
• "Biomarkers in Acute Coronary Syndromes" 
  1/1/2005
• "Advanced Diagnostics-Strategy for Growth" 
  1/1/2005
• "Advanced Diagnostics and Laboratory Automation" 
  Boston, MA - 1/1/2005
• Cardiology Grand Rounds: "The Role of Cardiac Troponin l in the Acute Coronary Syndrome." 
  VA Boston Healthcare System, West Roxbury, MA - 1/1/2005
• "Molecular Pathology A Strategy for Growth for Academic, Hospital-Based Clinical Laboratories." 
  1/1/2004
• "Trends in Clinical Pathology" 
  Boston, MA - 1/1/2004
• "Evaluation of the effectiveness of thrombolytic agents in acute coronary syndromes using cardiac markers." 
  Institute of Pharmacy at the University Cyril and Methodius, Macedonia - 1/1/2003
• "Fetal lung maturity" 
  1/1/2003
• "Current trends in laboratory diagnosis of acute coronary syndromes." 
  Department of Cardiology, Clinical Center and Medical School, Skopje, Macedonia - 1/1/2002
• "Cardiac Markers" 
  1/1/2002
• "Current and Future Trends in Hospital-Based Laboratory Medicine" 
  Phoenix, AZ - 1/1/2002
• "Evolution of fetal lung maturity testing." 
  Brigham & Women's Hospital - 1/1/2001
• "Reflexive Testing in the Clinical Laboratories." 
  Philadelphia, PA - 1/1/2001
• "Cardiac Markers, New Frontiers." 
  Westboro, MA - 1/1/2001
• "The role of the clinical laboratories in managing patients with Acute Coronary Syndromes." 
  Medical School at the University Cyril and Methodius, Skopje, Macedonia - 1/1/2000
• "Fetal lung maturity testing-New developments." 
  Brigham & Women's Hospital - 1/1/2000
• "The role of the clinical laboratory in managing patients with acute coronary syndromes." 
  Dana-Farber Cancer Institute Clinical Laboratories - 1/1/1999
• Join now to see all

Other

• Lean Tools in the Medical Laboratory 
  Milenko Jovan Tanasijevic, MD, Health Leaders Media
  7/1/2009
• Patient Safety and Communication Practices in Laboratory Medicine. 
  Milenko Jovan Tanasijevic, MD, National Quality Forum
  5/1/2009